Johnson & Johnson Innovation – JJDC — Full Portfolio

Rapport is a biopharmaceutical company developing novel therapeutics.

BiotechHealthtechMedical Devices

ACAbe Ceesay(President)CGCheryl GaultinDr. SevignyAbraham N. Ceesay(President and Chief Executive Officer and Director)

Co-investorsARARCH Venture PartnersSOSofinnova VenturesCACapital GroupTHThird Rock Ventures

Biotech

Co-investorsKUKurma PartnersSOSofinnova PartnersM M VenturesSRSR One Capital Management

Bright Peak Therapeutics is a biotechnology company developing multi-functional PD-1 inhibitors for cancer immunotherapy, based on its EDC protein-engineering platform.

BiotechHealthtechSan Diego, US

VPVijaya Pattabiraman(Co-founder & Chief Technology Officer)inJBJeffrey Bode(Scientific co-founder; Professor at ETH Zürich)inFWFredrik Wiklund(Chief Executive Officer)Christine Siu(Director)MRMichael Rosenzweig(Director)Bertolt Kreft(Executive Officer)

Co-investorsRARA CapitalVEVersant VenturesVEVenrockALAlexandriaBLBlackRockFIFidelity Investments+2 more

Citryll is a clinical-stage biotech developing CIT-013, an antibody therapy that targets extracellular traps by selectively binding citrullinated histones to both inhibit new trap formation and clear existing ones.

BiotechHealthtechMedical DevicesOss, NL

RCRenato Chirivi(Co-founder (former CSO))in

BoardPaul Peter Tak(Chair of the Board)

Co-investorsPUPureos BioventuresBIBioGeneration VenturesFOForbionSESeventure PartnersBOBOMCUCurie Capital+1 more

CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.

BiotechHealthtech

AFAnthony Fordin

Co-investorsALAlta PartnersLOLongitude CapitalABabrdn plcINIntermediate Capital GroupNENew Leaf Venture PartnersPAPappas Capital+2 more

Loci Orthopaedics develops extremity orthopaedic technologies, including its InDx device for the thumb base joint, using evidence-based design to address unmet clinical needs.

HealthtechMedical DevicesGalway, IE

BBBrendan Boland(Co-founder & Executive Chairperson)Gerry(Co-founder)Barry(CEO)Paul(Finance Leader)John(VP Technical Operations)

Co-investorsSESeroba Life SciencesLALaunch Capital

Mestag Therapeutics is an immunology company developing first-in-class agonist antibody therapies for cancer and inflammatory diseases based on fibroblast biology, and operates a RAFT platform for discovering new drug targets.

AI & Machine LearningBiotechHealthtech

SHSusan Hill(Chief Executive Officer)inMichael B. Brenner(Founder)Chris Buckley(Founder)MCMark Coles(Founder)inSoumya Raychaudhuri(Founder)David A. Tuveson(Founder)

Co-investorsGVGV (Google Ventures)FOForbionNONorthpond VenturesSVSV Health InvestorsJJJJDC

ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.

BiotechHealthtechMedical DevicesAnn Arbor, US

DZDavid Zacks(Co-Founder & Chief Scientific Officer)inDEDavid Esposito(Executive Officer, Director)inConstance Chang(Executive Officer)JKJohn K Freshley(Executive Officer, Director)inJAJeffrey A Jamison(Executive Officer)in

BoardAFAaron Fletcher(Director)in

Co-investorsEXExSight VenturesINInvest MichiganNONovartis Venture FundVIVisionary VenturesBIBios PartnersINInFocus Capital Partners, LLC+3 more

Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space.

BiotechHealthtechMedical Devices

Co-investorsARArboretum VenturesMAMaverick Ventures IsraelVIVisionary VenturesCACatalio Capital ManagementLILifeSci Venture PartnersSESequoia Capital+1 more

SpectraWAVE develops optical and computational imaging technologies to diagnose and guide treatment decisions for patients with coronary artery disease and cardiovascular disease.

AI & Machine LearningDeep TechHealthtechMedical DevicesBedford, US

ENEman Namati(President & CEO)inGTGuillermo Tearney(Founder; Professor of Pathology, Massachusetts General Hospital)GSGregg Stone(Founder; Professor of Medicine, Mount Sinai Heart Health System)JMJames Muller(Founder; Cardiologist, Brigham and Women's Hospital)inJeffrey O'Donnell(Founder; Managing General Partner, Runway Healthcare)VWVivek Walimbe(Chief Operating Officer)in

Co-investorsLULumira VenturesS3S3 VenturesSVSV Health InvestorsDEDeerfield Management Company

Georgiamune is a biopharmaceutical company developing targeted immunomodulator drugs that activate or down-modulate immune signaling pathways to treat cancer and autoimmune diseases.

BiotechDeep TechHealthtechGaithersburg, US

SNSamir N. Khleif(Founder & CEO)inRIRamy Ibrahim(Chief Medical and Strategy Officer)inMMMikayel Mkrichyan(Senior Vice President of Science and Discovery)SSSarah Sharman(Vice President of IP Legal Affairs)

BoardSPSean Parker(Director)EVElena Viboch(Director)in

Board seatNancy Ondovik· per SEC Form D · $131.9M raise · filed Aug 2026

Co-investorsCACatalio Capital Management, LPHAHAWKTAILLALauder PartnersPRPrevail Venture CapitalGEGeneral Catalyst

Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients.

BiotechHealthtechLongevity

Co-investorsATAtlas VentureDRDroia VenturesECEcoR1 CapitalGVGV (Google Ventures)THThe Column GroupJJJJDC+1 more

Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins.

BiotechHealthtechPhiladelphia, US

KOKaryn O'Neil(Executive Officer, Director)Susan Dillon(Founder)inMark V. Laurenzi(Executive Officer)

BoardElizabeth Anderson(Director)Bruce Peacock(Director)

Co-investorsAVAvego BioScience CapitalHEHealthCapAGAgent CapitalBIBiotechnology Value FundCOCowen Healthcare InvestmentsNONorthpond Ventures

ARO Network is an edge network infrastructure platform designed for AI agents to operate on local devices and residential networks using users' real-world resources.

AI & Machine LearningCrypto & Web3Data & Infrastructure

Co-investorsCVCVP NoLimitEVEv3 Ventures LlcNONo Limit Holdings (NLH)1717SigmaNONorte VenturesONOnevc Venture Partners Llc

Datavant Connect is a data connectivity platform that enables healthcare and life sciences organizations to share and link datasets while maintaining privacy compliance through tokenization technology.

AI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHealthtech

KAKyle Armbrester(Chief Executive Officer)in

Co-investorsFLFlex Capital PartnersGRGrand VenturesHEHealth Catalyst CapitalSISixth StreetTETensility Venture PartnersTRTRANSFORMATION CAPITAL

Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.

BiotechHealthtech

Co-investorsFAFACIT (Fight Against Cancer Innovation Trust)HEHealthCapLULumira VenturesSESeroba Life SciencesVEVenture OntarioYSYsios Capital+2 more

BiotechSan Diego, US

Han Ying(Director)Usman Nassim(Director)Weiguo Yu(Executive Officer)Renate Parry(Director)Ying Luo(Director)inSongjiang Ma(Director, Executive Officer)

HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.

HealthtechMedical DevicesLexington, US

CVCarl Vause(Executive Officer, Director)inMSMira Sahney(Executive Officer, Director)inDMDavid Myung(Director)

BoardMichael Hawkins(Director)WHWende Hutton(Director)inWHWilliam Harrington(Director)in

Co-investorsCACanaan PartnersOUOUP (Osage University Partners)TRTreo Ventures, Llc

Moon Surgical develops the Maestro robotic surgery system, a digital surgical robotics platform used by surgeons to perform procedures.

HealthtechMedical DevicesRoboticsParis, FR

BGBrice Gayet(Founder)inAOAnne Osdoit(Chief Executive Officer)inEEEric Ermenault(Chief Commercial Officer)inARAnne Renevot(Chief Financial Officer)inVFViola Fleig(Chief Operations Officer)inDNDavid Noonan(Chief Technology Officer)in

Co-investorsSOSofinnova PartnersNVNVIDIACACathay HealthNVNVentures

PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.

BiotechHealthtechMedical DevicesMalvern, US

Ashutosh Chilkoti(Director)Joel Sussman(Executive Officer)JMJonathan Mow(Chief Executive Officer)in

BoardJames Barrett(Director)Michael Gutch(Director)Justin Klein(Director)

Co-investorsMOMountain Group CapitalNENew Enterprise Associates (NEA)HAHatteras Venture Partners

HealthtechBelmont, US

Barry Cheskin(Executive Officer, Director)S. Arieh Zak(Executive Officer)George Green(Executive Officer)

BoardDrew Schiff(Director)Michael Carusi(Director)Lou Bock(Director)

Co-investorsAIAisling CapitalARArcher Capital GroupARArcher Venture CapitalLILightstone VenturesSCScale Venture Partners

HealthtechHouston, US

JNJoanna Nathan(Executive Officer, Director)in

BoardMicheal Haimour(Director)Ed Boyle(Director)Sean Churchill(Director)

Co-investorsHOHouston Angel NetworkNENew World AngelsTMTMC Venture Fund

Pulmocide is a biopharmaceutical company developing inhaled therapies for difficult-to-treat respiratory diseases, currently focused on respiratory fungal infections such as pulmonary aspergillosis.

BiotechHealthtech

PSPete Strong(Co-founder)Garth Rapeport(Co-founder)inKazuhiro Ito(Co-founder)inJohn Murray(Co-founder)inDMDavid Mantusin

Co-investorsADAdjuvant CapitalF-F-Prime CapitalJEJeito CapitalLOLongwood FundSRSR One Capital ManagementSVSV Health Investors+2 more

Rondo Therapeutics is an immuno-oncology biopharmaceutical company developing bispecific/multispecific antibody therapeutics designed for tumor-selective targeting to treat solid tumors while sparing healthy tissue.

BiotechHealthtech

SFShelley Force Aldred(Co-Founder & Chief Executive Officer)inNTNathan Trinklein(Co-Founder, President & CSO)inKatherine(Chief Development Officer)Thomas(Chief Medical Officer)

Co-investorsCACanaan PartnersRERed Tree VentureSVSV Health InvestorsNONovo Holdings

Solenic Medical is a medical company; this page is an investor contact form and does not describe the company's products or technology in detail.

Medical DevicesCollege Station, US

JYJames Y Lancaster(Executive Officer, Director)in

BoardJohn Hodock(Director)Robert Calvin Goforth(Director)

Co-investorsSHShangBay Capital LLCSUSugati Ventures

HealthtechStamford, US

Patrick Lopath(Chief Operating Officer)inThomas Alan Dunlap(Chief Executive Officer)Madhu Ayyagari(Chief Executive Officer)

BoardRichel Liu(Director)Deng Mao(Director)inHirak Parikh(Director)

Astoria, US

Demetrius Michael Karagas(Executive Officer, Director)SGSteven Gutentag(Founder)in

BoardRKRebecca Kaden(Director)in

Co-investorsALAlpha PartnersCOComcast VenturesCOConnetic VenturesCVCVS Health VenturesEVEvolution VC PartnersFOForeground Capital+14 more

Transforming the lives of patients through a functional cure for Type 1 Diabetes

BiotechSan Diego, US

Brittany Bradrick(Executive Officer)Anne Sandan(Executive Officer)Elizabeth Bui(Executive Officer)Steve White(Executive Officer)HFHoward Foyt(Executive Officer)inKevin D'Amour(Executive Officer)in

Co-investorsARArtis VenturesBABain Capital Life SciencesRARA CapitalSASanderling VenturesTHThe Vertical GroupRERed Tree Venture

Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.

AI & Machine LearningDigital HealthHealthtechBaltimore, US

RSRyan Sysko(Executive Officer, Director)inSCSuzanne Clough(Executive Officer)inKMKevin McRaith(President and CEO)inAIAnand Iyer(Chief AI Officer)inCBChris Bergstrom(Executive Officer)in

BoardTerry Lierman(Director)

Co-investorsMEMerck Global Health Innovation FundSASamsung VenturesASAsset Management CompanyDIDigiTx Partners LLCEXExcel Venture ManagementTCTCP Venture Capital+1 more